CXCL12 and central nervous system cancer: As it was previously mentioned, CXCL12, also known as SDF-1 is enriched in hypoxic areas and it is related to glioma progression, cancer cell–TME interaction, cellular invasion, and tumor angiogenesis [67,74,75].